Application 050605
- Type
- NDA
- Sponsor
- GLAXOSMITHKLINE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEFTIN | CEFUROXIME AXETIL | TABLET;ORAL | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 002 | CEFTIN | CEFUROXIME AXETIL | TABLET;ORAL | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 003 | CEFTIN | CEFUROXIME AXETIL | TABLET;ORAL | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N050605-001 | CEFTIN | CEFUROXIME AXETIL | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | |
| N050605-002 | CEFTIN | CEFUROXIME AXETIL | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | |
| N050605-003 | CEFTIN | CEFUROXIME AXETIL | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050605-002 | CEFTIN | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N050605-003 | CEFTIN | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N050605-001 | CEFTIN | EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1987-12-28 | 301d65b070ca… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefuroxime Axetil | CEFUROXIME AXETIL | Coupler LLC | 2c619a79-6b69-b9fa-e063-6394a90a8f27 | 2025-01-23 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime Axetil | CEFUROXIME AXETIL | Coupler LLC | 2c3a502f-8e72-c4d2-e063-6394a90a6fa5 | 2025-01-21 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime axetil | CEFUROXIME AXETIL | A-S Medication Solutions | 84593261-838c-433a-8d9d-1d37b11058da | 2024-09-11 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime axetil | CEFUROXIME AXETIL | NuCare Pharmaceuticals,Inc. | 83476d51-be74-748b-e053-2a91aa0a3d36 | 2024-07-15 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime axetil | CEFUROXIME AXETIL | NuCare Pharmaceuticals,Inc. | 8c3c1c85-cbce-66e2-e053-2a95a90a94fe | 2024-06-18 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime Axetil | CEFUROXIME AXETIL | NorthStar Rx LLC | fd79c41e-b0e9-47dc-a3ce-caacdc66bc96 | 2024-04-30 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime Axetil | CEFUROXIME AXETIL | Aurobindo Pharma Limited | faef39e9-d793-4191-a728-310f6fab759d | 2024-04-29 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime Axetil | CEFUROXIME AXETIL | Rising Pharma Holdings, Inc. | 66f8d37f-aebc-4435-af80-dfd7b3770088 | 2024-04-29 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime Axetil | CEFUROXIME AXETIL | A-S Medication Solutions | eb180b38-f8c8-4dbf-856a-347d3ebac857 | 2024-02-27 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime axetil | CEFUROXIME AXETIL | A-S Medication Solutions | c89e8f4d-96c0-44c6-906a-b803141920b1 | 2024-02-13 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime Axetil | CEFUROXIME AXETIL | A-S Medication Solutions | bcf7870a-7e45-4ae1-a9b4-457e4781886a | 2024-01-04 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
| Cefuroxime axetil | CEFUROXIME AXETIL | Proficient Rx LP | e9a020ec-e446-469a-b1d1-07e82eefa305 | 2023-07-01 | Warnings, Adverse reactions | CEFUROXIME AXETIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 66686 | SUPPL | 2021-03-09 |
| 66662 | SUPPL | 2021-03-09 |
| 58451 | SUPPL | 2019-04-26 |
| 58434 | SUPPL | 2019-04-26 |
| 50086 | SUPPL | 2017-10-18 |
| 50071 | SUPPL | 2017-10-17 |
| 45977 | SUPPL | 2016-12-01 |
| 45950 | SUPPL | 2016-11-23 |
| 30156 | SUPPL | 2015-08-28 |
| 17922 | SUPPL | 2015-08-27 |
| 30155 | SUPPL | 2015-07-07 |
| 39033 | SUPPL | 2015-07-01 |
| 30154 | SUPPL | 2014-09-23 |
| 30153 | SUPPL | 2014-09-23 |
| 39032 | SUPPL | 2014-09-22 |
| 39031 | SUPPL | 2014-09-22 |
| 30152 | SUPPL | 2007-07-27 |
| 17921 | SUPPL | 2007-07-24 |
| 30151 | SUPPL | 2004-06-07 |
| 17920 | SUPPL | 2004-06-07 |
| 7876 | SUPPL | 2002-07-24 |
| 17919 | SUPPL | 2002-04-11 |
| 7875 | SUPPL | 2002-04-11 |
| 17918 | SUPPL | 2002-03-29 |
| 7874 | SUPPL | 2002-03-29 |
| 30150 | SUPPL | 1999-08-24 |
| 22166 | SUPPL | 1999-08-24 |